Clear visual breakdown: for every ₹100 earned, see how much flows to salaries, operating costs, government taxes, EPS profit, and your share.
Profit Conversion
₹27.9/ ₹100
High profit margin business
Human Capital & Talent
₹12.0/ ₹100
Workforce salaries, engineers & talent
Earnings Per Share (EPS)
₹10.43/ share
Annual profit generated per stock unit
Shareholder Payout
₹11.1/ ₹100
Direct cash dividends & buybacks
Multi-Stage Money Stream (Sankey Flow)
Hover or drag nodes to inspect connections and money volumeMode: Every ₹100 Company Sales
Revenue
Materials / Production
Human Capital (Talent)
Government Taxes
Net Profit / EPS
Dividends & Reinvestment
Topline Money Inflow100.0%
Gross Commercial Revenue
₹100.00per ₹100 sales
For every ₹100 collected by ANTHEM BIOSCIENCES LTD from customers and clients globally.
Raw Materials, Energy & Inventory38.2%
Direct Production & Materials (COGS)
₹38.24per ₹100 sales
Direct physical costs required to produce the company's products, chip fabrication, server components, or merchandise.
Salaries, Benefits, R&D & Talent12.0%
Human Capital & Engineering Workforce
₹12.00per ₹100 sales
Compensation paid to software engineers, technicians, designers, operators, and staff driving the business forward.
Cloud Servers, Sales, Marketing & Legal25.8%
Operating, Tech & Administrative (SG&A)
₹25.82per ₹100 sales
Essential business operations including data center infrastructure, global marketing, compliance, and office facilities.
Interest to Bank Lenders & Bondholders0.3%
Debt Servicing & Financing Costs
₹0.31per ₹100 sales
Cost of borrowed capital. Lower interest outlays indicate low debt dependency and strong financial solvency.
Direct Corporate Tax Paid to State10.9%
Government Corporate Taxes
₹10.94per ₹100 sales
Statutory income taxes contributed to national infrastructure, roads, defense, and public governance.
Pure Profit Belongs to Shareholders27.9%
Net Bottom-Line Profit (EPS Engine)
₹27.86per ₹100 sales
The ultimate earnings of the company. This forms your Diluted EPS (₹10.43/share) and belongs entirely to equity owners.
Cash Deposited to Investor Bank Accounts7.0%
Direct Cash Dividends
₹6.96per ₹100 sales
Actual liquid profits credited directly into your brokerage or bank account as passive dividend cash flow.
Reduces Share Count to Elevate EPS4.2%
Share Repurchases (Buybacks)
₹4.18per ₹100 sales
The company buys its own shares off the market and retires them, making your remaining shares represent a larger slice of future profits.
Reinvested in New Factories, AI & Tech9.9%
Capital Expenditure (Growth CapEx)
₹9.94per ₹100 sales
Long-term capital assets purchased: next-gen server clusters, robotics, retail stores, or production assembly lines.
Retained Earnings on Balance Sheet16.7%
Treasury Reserves & War Chest
₹16.72per ₹100 sales
Cash reserves stored in bank deposits, treasuries, and safe liquid investments to withstand crises and fund sudden strategic acquisitions.
Shareholder Capital Simulator: Where Does Your Investment Go?
Select or type any investment amount to see how much commercial activity and earnings your money commands in ANTHEM BIOSCIENCES LTD.
Your Investment:₹50,000 (~54.6 shares at ₹915.55/share)
Annual Revenue
₹2,045
Generated by your capital
Human Capital
₹245
Engineers & staff salaries
Taxes Paid
₹224
Public infrastructure
Your Net Earnings
₹570
Annual profit earned by you (1.1% yield)
Cash Dividend
₹143
Direct cash to your bank
Growth CapEx
₹203
Reinvested in tech & expansion
How to read this flow diagram as an investor:Revenue represents gross sales (₹100). Before any profit can reach you, the company must first pay suppliers (COGS), its workforce & engineers (Human Capital), rent & technology (SG&A), lenders (Interest), and the government (Taxes). What remains is Net Profit (Diluted EPS). Healthy companies divide this profit between Cash Dividends, Share Buybacks (retiring shares to boost your percentage ownership), and CapEx Reinvestment to build new capacity for future years.
Key Fundamentals & Ratios
Real-Time Screener Matrix
Market Cap
₹51,594 Cr
Large Cap
Current Price
₹915.55
+0.22% today
52W High / Low
₹977.55 / ₹579.15
Past 52 weeks historical
Stock P/E
84.8
Forward: 60.0
Book Value
₹58.18
Price to Book: 15.74x
Dividend Yield
0.22%
Annualised distribution
Return on Equity (ROE)
20.4%
Shareholder returns efficiency
1-Year Return
+31.15%
52W change percent
52W Low: ₹579.15Current price sits at 84% of 52W range52W High: ₹977.55
About ANTHEM BIOSCIENCES LTD
Healthcare & Pharma
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.
TTM Revenue₹2,064 Cr
Net Profit Margin29.7%
Operating Margin45.9%
EPS (Trailing)₹10.8
Peer Comparison
Comparing ANTHEM BIOSCIENCES LTD with leading competitors in Healthcare & Pharma (Indian Market)
Data Provenance & Regulatory DisclosureSource: NSE/BSE Statutory Filings
Quotes are delayed by at least 15 minutes. Financial metrics and disclosures are cross-referenced with periodic statutory disclosures from the National Stock Exchange of India (NSE) and BSE India. This content is provided strictly for educational and portfolio analytics purposes, and does not constitute investment advice or Buy/Sell recommendations.
